Can Allopurinol Cause Cholestasis?
Yes, allopurinol can cause cholestatic liver injury, though it is rare; the FDA label explicitly lists cholestatic jaundice as a recognized adverse reaction, and this can occur as part of a severe hypersensitivity syndrome that may be life-threatening. 1
Clinical Evidence and Mechanism
The FDA drug label for allopurinol clearly documents cholestatic jaundice as an adverse reaction occurring in patients who develop severe hypersensitivity reactions 1. These reactions typically manifest with:
- Fever, chills, and arthralgias
- Skin rash (often severe)
- Eosinophilia
- Cholestatic jaundice
- Mild leukocytosis or leukopenia
The syndrome can progress to irreversible hepatotoxicity and, rarely, death 1. The FDA label emphasizes that allopurinol should be discontinued immediately at the first appearance of skin rash or other signs of allergic reaction 1.
Patterns of Liver Injury
Allopurinol-induced cholestatic injury can present in several forms:
- Cholestatic hepatitis with granulomas: Case reports document granulomatous hepatitis with ductopenia and marked cholestasis 2, 3
- Vanishing bile duct syndrome: Rare but severe, potentially progressing to biliary cirrhosis 4
- Severe cholestatic liver failure: Documented cases requiring liver transplantation 5
The histopathologic findings typically show marked cholestasis in the parenchyma, granulomas in portal areas, and sometimes vacuolar degeneration of interlobular bile ducts 2.
Timing and Risk Factors
The hypersensitivity syndrome typically begins 2-6 weeks after starting allopurinol 2, though the FDA label notes symptoms may develop in approximately 1 week 1.
Critical risk factor: The occurrence of hypersensitivity reactions, including cholestatic injury, is increased in patients with decreased renal function receiving thiazides and allopurinol concurrently 1. This is particularly important since allopurinol is commonly prescribed for hyperuricemia in patients with renal impairment.
Clinical Recognition and Management
Diagnostic Features
When drug-induced cholestatic injury is suspected, diagnosis requires 4:
- Clinical suspicion and careful drug history
- Temporal relationship between drug intake and liver disease
- Exclusion of other disorders
- Cholestatic pattern: AP >2× ULN or ALT/AP ratio <2
Immediate Action Required
Discontinue allopurinol immediately if any of the following develop 1:
- Skin rash
- Painful urination or blood in urine
- Irritation of the eyes
- Swelling of lips or mouth
- Jaundice
- Anorexia, weight loss, or pruritus
Management Approach
The only effective treatment for drug-induced cholestasis is immediate withdrawal of the drug 4. Additional measures include:
- Monitor liver tests closely: Repeat within 7-10 days if cholestatic DILI is suspected 6
- Abdominal ultrasound: To exclude biliary obstruction 4
- Liver biopsy: Not mandatory initially, but consider if severe, progressive, or prolonged course (>3 months) 4
- Corticosteroids: May be beneficial in hypersensitivity-induced cholestasis, though controlled trial data are lacking 4. Case reports show successful recovery with early systemic corticosteroid therapy 2
Prognosis
The outcome after drug withdrawal is generally good 4, with normalization of serum liver tests within 3 months in most cases. However:
- Cholestatic injury improves more slowly than hepatocellular injury 6
- Blood tests typically return to baseline within 6 months 6
- Rare progression to vanishing bile duct syndrome can cause permanent liver damage, biliary fibrosis, and cirrhosis 6
- Severe cases may require liver transplantation 5
Critical Clinical Pitfall
Do not rechallenge with allopurinol once cholestatic injury has occurred—this is potentially harmful, unethical, and not indicated 4. The FDA label warns that treatment should be discontinued immediately if a rash develops, as skin reactions can be severe and sometimes fatal 1.